Article
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers
14 Jun 2025
Abstract excerpt
Approximately half of all cancers bear mutations in the tumor suppressor p53. Despite decades of research studying p53 function, treatment of p53-mutant cancers remains challenging owing to the effects of p53 mutations on many complex and interrelated signaling networks that promote tumor metastasis and chemoresistance. Mutations in p53 promote tumor survival by dysregulating cellular homeostasis and preventing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
